Switch to:
Allergan PLC (NYSE:AGN)
EV/EBITDA
33.32 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Allergan PLC's enterprise value is $140,325 Mil. Allergan PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2016 was $4,211 Mil. Therefore, Allergan PLC's EV/EBITDA ratio for today is 33.32.

AGN' s EV/EBITDA Range Over the Past 10 Years
Min: -224.1   Max: 386.1
Current: 33.37

-224.1
386.1

During the past 13 years, the highest EV/EBITDA Ratio of Allergan PLC was 386.10. The lowest was -224.10. And the median was 10.10.

AGN's EV/EBITDA is ranked lower than
76% of the 552 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 17.38 vs. AGN: 33.37 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Allergan PLC's stock price is $243.27. Allergan PLC's earnings per share for the trailing twelve months (TTM) ended in Jun. 2016 was $10.12. Therefore, Allergan PLC's P/E Ratio for today is 24.04.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Allergan PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=140325.013/4210.9
=33.32

Allergan PLC's current Enterprise Value is $140,325 Mil.
Allergan PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2016 was 305.8 (Sep. 2015 ) + 1085.8 (Dec. 2015 ) + 1484 (Mar. 2016 ) + 1335.3 (Jun. 2016 ) = $4,211 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Allergan PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=243.27/10.12
=24.04

Allergan PLC's share price for today is $243.27.
Allergan PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2016 was 13.29 (Sep. 2015 ) + -2.2 (Dec. 2015 ) + 0.47 (Mar. 2016 ) + -1.44 (Jun. 2016 ) = $10.12.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Allergan PLC Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -21.926.715.6310.4711.718.7218.2957.4188.6362.09

Allergan PLC Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
ev2ebitda 37.8222.6555.9788.63455.49174.1497.2662.0936.7832.17
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK